TNFα antagonist therapy in axial spondyloarthritis: Can we do better?

被引：7
|
作者：
Prati, Clement [1 ]
Claudepierre, Pascal [2 ]
Goupille, Philippe [3 ]
Thao Pham [4 ]
Wendling, Daniel [1 ]
机构：
[1] Univ Franche Comte, CHRU Besancon, Serv Rhumatol, Blvd Fleming, F-25030 Besancon, France
[2] Univ Paris Est Creteil, Hop Henri Mondor Creteil, AP HP, Serv Rhumatol,EA EpiDermE, F-94000 Creteil, France
[3] Univ Tours, CHU Tours, CNRS, Serv Rhumatol,UMR 7292, F-37000 Tours, France
[4] Aix Marseille Univ, CHU St Marguerite, AP HM, Serv Rhumatol, F-13000 Marseille, France
来源：
JOINT BONE SPINE | 2016年 / 83卷 / 03期
关键词：
Spondyloarthritis; Treatment; TNF alpha antagonists; Immunogenicity; ANKYLOSING-SPONDYLITIS; RHEUMATOLOGY SFR; FRENCH SOCIETY; INFLIXIMAB; DISEASE; ADALIMUMAB; EFFICACY; RECOMMENDATIONS; IMMUNOGENICITY; MULTICENTER;
D O I：
10.1016/j.jbspin.2016.01.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [31] HIV screening: How we can do better
    Kirchner, Jeffrey T.
    JOURNAL OF FAMILY PRACTICE, 2014, 63 (07): : 383 - 387
  • [32] Revascularization for Heart Failure Can We Do Better?
    Ohman, E. Magnus
    Velazquez, Eric J.
    JACC-HEART FAILURE, 2018, 6 (06) : 527 - 529
  • [33] Malaria: How Are We Doing and How Can We Do Better?
    Rosenthal, Philip J.
    John, Chandy C.
    Rabinovich, N. Regina
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 100 (02): : 239 - 241
  • [34] Current therapy with TNFα blocking agents for ankylosing spondylitis and undifferentiated spondyloarthritis
    Brandt, J
    Sieper, J
    Braun, J
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2004, 63 (03): : 203 - 210
  • [35] Better Quantification of Syndesmophyte Growth in Axial Spondyloarthritis
    Ward, Michael M.
    Tan, Sovira
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (08)
  • [36] Better Quantification of Syndesmophyte Growth in Axial Spondyloarthritis
    Michael M. Ward
    Sovira Tan
    Current Rheumatology Reports, 2018, 20
  • [37] Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy
    Rodriguez, Valeria Rios
    Poddubnyy, Denis
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2017, 9 (08) : 197 - 210
  • [38] Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
    Linde, Louise
    Ornbjerg, Lykke Midtboll
    Heegaard Brahe, Cecilie
    Wallman, Johan Karlsson
    Di Giuseppe, Daniela
    Zavada, Jakub
    Castrejon, Isabel
    Diaz-Gonzalez, Federico
    Rotar, Ziga
    Tomsic, Matija
    Glintborg, Bente
    Gudbjornsson, Bjorn
    Geirsson, Arni Jon
    Michelsen, Brigitte
    Kristianslund, Eirik Klami
    Santos, Maria Jose
    Barcelos, Anabela
    Nordstrom, Dan
    Eklund, Kari K.
    Ciurea, Adrian
    Nissen, Michael
    Akar, Servet
    Hejl Hyldstrup, Lise
    Krogh, Niels Steen
    Hetland, Merete Lund
    Ostergaard, Mikkel
    RHEUMATOLOGY, 2023, 63 (07) : 1882 - 1892
  • [39] High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis
    de Wolff, Liseth
    Arends, Suzanne
    Brouwer, Elisabeth
    Bootsma, Hendrika
    Spoorenberg, Anneke
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [40] Can we currently and confidently assess the true burden of illness due to non-radiographic axial spondyloarthritis?
    van der Linden, S.
    Khan, M. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : 963 - 965
12345